# Artrya Limited

- Location (FDA's records): Perth, AU
- FDA decisions: 2 (2025–2025): 2 510(k) clearances
- Product codes: QIH (2)
- Predicates its devices cite: 3 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Caristo Diagnostics, Ltd.: 1 (https://510kreport.com/company/caristo-diagnostics)
- Circle Cardiovascular Imaging, Inc.: 1 (https://510kreport.com/company/circle-cardiovascular-imaging)

## Its most-cited devices
- K243038: Salix Central (2025), cited by 1

## Recent decisions
- K251837: Salix Coronary Plaque (V1.0.0) (Aug 20, 2025)
- K243038: Salix Central (Mar 27, 2025)

Source page: https://510kreport.com/company/artrya